RxDoctor Payments Data

Durr-E-Shahwaar Sayed, DO

Family Medicine · Glassboro, NJNPI 1821228263

Payments from drug & device makers

$2,413in general payments, 2019–2025

Across 155 payments — averaging $15.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$508
  • Novo Nordisk$432
  • Abbott$307
  • Lilly USA, LLC$200
  • Astellas Pharma US Inc$138
  • Boehringer Ingelheim$113
  • plus $715 from 19 others

What the payments were for

  • Food & beverage$2,405100%
  • Education$80%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,413 in reported general payments places this provider in the 75th percentile of 2,084 family medicine providers in New Jersey.

See all family medicine providers in New Jersey

Medicare billing

Part B allowed, 2024
$91,827
Medicare patients
219
Services billed
955

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban68$67,569
Trelegy ElliptaFluticasone/Umeclidin/Vilanter55$39,774
JardianceEmpagliflozin47$38,800
TrulicityDulaglutide18$25,076
JanuviaSitagliptin Phosphate19$21,083
FarxigaDapagliflozin Propanediol13$18,003
LinzessLinaclotide30$16,500
OzempicSemaglutide16$14,863
Breo ElliptaFluticasone/Vilanterol29$14,637
MyrbetriqMirabegron29$13,988
XareltoRivaroxaban20$13,896
Synjardy XrEmpagliflozin/Metformin Hcl13$11,649
TradjentaLinagliptin20$11,110
BrilintaTicagrelor15$11,084
Aripiprazole27$9,184

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$55$67,56968 claims
Boehringer IngelheimJardiance, Synjardy Xr, Tradjenta$113$61,55980 claims
GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta$101$59,17597 claims
AstraZenecaFarxiga, Brilinta$75$29,08728 claims
Lilly USA, LLCTrulicity$200$25,07618 claims
MerckJanuvia$66$21,08319 claims
AbbVieLinzess, Synthroid$508$18,49252 claims
Novo NordiskOzempic$432$14,86316 claims
Astellas Pharma US IncMyrbetriq$138$13,98829 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$19$2,548248 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,084 family medicine providers in New Jersey.

Other family medicine in Glassboro

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →